| Company Name: | Healthcare Services Group, Incorporated | | Ticker Symbol: | HCSG | | | WWW Address: | www.hcsgcorp.com | | CEO: | Daniel P. McCartney | | No. of Employees: | 4,500 | | Common Issue Type: | CS | | Business Description: | The Company provides housekeeping, laundry, linen, facility maintenance and food services to the health care industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Business Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 20.2 |  0.04 | 19.6 | 20.78 | 20.23 | 20.52 | 20.05 | 66466 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 878.7 | 43.5 | 0.54 | 0.60 | 0.58 | 28.4 | 4.0 | 21.15 - 13.12 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 20.16 | $ | | PE Ratio - LTM | 28.4 | |
| Market Capitalisation | 876.6 | mil |
| Latest Shares Outstanding | 43.5 | mil |
| Earnings pS (EPS) | 0.60 | $ |
| Dividend pS (DPS) | 0.58 | ¢ |
| Dividend Yield | 4.0 | % |
| Dividend Payout Ratio | 97 | % |
| Revenue per Employee | 133,937 | $ |
| Effective Tax Rate | 38.5 | % |
| Float | 40.4 | mil |
| Float as % of Shares Outstanding | 92.9 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 6.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 14.4 | % |
| EBITDA Margin | 7.5 | % |
| Pre-Tax Profit Margin | 7.6 | % |
| Assets Turnover | 2.5 | % |
| Return on Assets (ROA) | 11.4 | % |
| Return on Equity (ROE) | 14.8 | % |
| Return on Capital Invested (ROCI) | 14.8 | % |
| Current Ratio | 5.4 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 4.07 | $ |
| Cash pS | 0.86 | $ |
| Book-Value pS | 4.82 | $ |
| Tangible Book-Value pS | 4.21 | $ |
| Cash Flow pS | 0.80 | $ |
| Free Cash Flow pS | -0.09 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.19 | |
| Price/Tangible Book Ratio | 4.79 | |
| Price/Cash Flow | 25.1 | |
| Price/Free Cash Flow | -234.7 | |
| P/E as % of Industry Group | 62.0 | % |
| P/E as % of Sector Segment | 66.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 10/13/2009 |
| Dividend Ex-Date | 10/20/2009 |
| Dividend Record Date | 10/22/2009 |
| Dividend Pay Date | 11/05/2009 |
| Dividend Amount | 200 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.80 |
| Current Dividend Yield | 4.0 |
| 5-Y Average Dividend Yield | 2.3 |
| Payout Ratio | 97.0 |
| 5-Y Average Payout Ratio | 57.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.1 | 101 | 822 | 872 |
| 4 Weeks | 20.65 | 19.08 | 19.75 | 2.1 | 96 | 984 | 15,743 |
| 13 Weeks | 21.15 | 17.25 | 17.67 | 14.1 | 106 | 1,676 | 100,586 |
| 26 Weeks | 21.15 | 17.08 | 17.48 | 15.3 | 96 | 1,842 | 228,433 |
| 52 Weeks | 21.15 | 13.12 | 15.90 | 26.8 | 103 | 2,258 | 560,015 |
| YTD | 21.15 | 13.81 | - | 26.6 | 103 | 2,237 | 505,600 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 20.13 | 20.08 | 19.34 | 18.49 | 17.72 | 0.54 | 0.43 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 8.38 | 97.9 | 8.34 |
| Income | 14.21 | 83.3 | 4.36 |
| Dividend | 43.34 | 97.5 | 30.55 |
| Capital Spending | -1.86 | NA | -20.71 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 13.51 | NA | 3.47 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 13.8 | 16.9 | 4.3 |
| Earnings % | 23.0 | 48.9 | -10.0 |
| EPS % | 22.7 | 46.2 | -10.4 |
| EPS $ | 0.10 | 0.06 | -0.07 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 71.44 |
| Current Ratio | 7.1 |
| Quick Ratio (Acid Test) | 6.3 |
| Liquidity Ratio (Cash) | 2.99 |
| Receivables Turnover | 6.7 |
| Average Collection Period | 54 |
| Working Capital/Equity | 88.0 |
| Working Capital pS | 4.48 |
| Cash-Flow pS | 0.75 |
| Free Cash-Flow pS | -0.25 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 15.34 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 18.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 8.8 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.09 |
| Tobin's Q Ratio | 3.53 |
| Current P/E Ratio - LTM | 28.40 |
| Enterprise Value (EV)/EBITDA | 18.61 |
| Enterprise Value (EV)/Free Cash Flow | -140.67 |
| Dividend Yield | 4.0 |
| Price/Tangible Book Ratio - LTM | 4.79 |
| Price/Book Ratio - LTM | 4.19 |
| Price/Cash Flow Ratio | 25.1 |
| Price/Free Cash Flow Ratio - LTM | -234.7 |
| Price/Sales Ratio | 1.32 |
| P/E Ratio (1 month ago) - LTM | 27.6 |
| P/E Ratio (26 weeks ago) - LTM | 27.7 |
| P/E Ratio (52 weeks ago) - LTM | 26.1 |
| 5-Y High P/E Ratio | 42.1 |
| 5-Y Low P/E Ratio | 15.4 |
| 5-Y Average P/E Ratio | 29.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 96 |
| P/E as % of Industry Group | 62.0 |
| P/E as % of Sector Segment | 66.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 28.4 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.73 |
| Tangible Book Value pS - LTM | 4.21 |
| Book Value pS - LTM | 4.82 |
| Capital Invested pS | 4.64 |
| Cash pS - LTM | 0.86 |
| Cash Flow pS - LTM | 0.80 |
| Free Cash Flow pS - LTM | -0.09 |
| Earnings pS (EPS) | 0.60 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1.64 |
| Free Cash Flow Margin 5YEAR AVG | 0.75 |
| Net Profit Margin | 4.4 |
| Net Profit Margin - 5YEAR AVRG. | 4.4 |
| Equity Productivity | 2.99 |
| Return on Equity (ROE) | 13.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.7 |
| Capital Invested Productivity | 2.99 |
| Return on Capital Invested (ROCI) | 13.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 13.7 |
| Assets Productivity | 2.50 |
| Return on Assets (ROA) | 10.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 10.9 |
| Gross Profit Margin | 14.4 |
| Gross Profit Margin - 5YEAR AVRG. | 14.0 |
| EBITDA Margin - LTM | 7.5 |
| EBIT Margin - LTM | 7.6 |
| Pre-Tax Profit Margin | 7.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 7.2 |
| Effective Tax Rate | 38.5 |
| Effective Tax Rate - 5YEAR AVRG. | 38.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 69 |
| Revenue per Employee | 133,937 |
| Net Income per Employee | 5,914 |
| Average Collection Period | 58 |
| Receivables Turnover | 6.7 |
| Day's Inventory Turnover Ratio | 11 |
| Inventory Turnover | 33.2 |
| Inventory/Sales | 2.7 |
| Accounts Payble/Sales | 1.54 |
| Assets/Revenue | 0.40 |
| Net Working Capital Turnover | 3.39 |
| Fixed Assets Turnover | 14.37 |
| Total Assets Turnover | 2.5 |
| Revenue per $ Cash | 16.07 |
| Revenue per $ Plant | 153.40 |
| Revenue per $ Common Equity | 2.99 |
| Revenue per $ Capital Invested | 2.99 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 6.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 7.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |